Navigation Links
FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
Date:9/30/2010

ype of action announced today."

The FDA previously took action against unapproved colchicine for injection products on Feb. 6, 2008. This ongoing initiative is designed to bring all unapproved medications, including single-ingredient oral colchicine, up to modern-day safety, efficacy, labeling, and quality standards by ensuring that they comply with FDA approval requirements. The FDA is committed to working with companies to ensure that marketed drugs are safe and effective, and meet appropriate standards for manufacturing and labeling.

For more information:

Oral Colchicine Federal Register Notice

http://www.ofr.gov/inspection.aspx#reg_F

FDA's Unapproved Drugs Web site http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm

Media Inquiries: Elaine Gansz Bobo, 301.796.7567, elaine.bobo@fda.hhs.gov

Consumer Inquiries: 888-INFO-FDA


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
3. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of GT4P in Patients With Urea Cycle Disorders
4. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
5. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
6. Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders
7. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
8. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
9. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
10. Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
11. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Developed by Roche under the trade name of ... the world. In Feb.26, 2010, it was approved by ... available in China all come ...
(Date:8/28/2015)... DRAPER, Utah , Aug. 28, 2015  Today, ... and Prevention,s (CDC) Contact Lens Health Week, 1-800 Contacts ... CDC has found that contact lens wearers who do ... the greatest risk for eye infections. ... cleaning their lenses, but a clean lens case is ...
(Date:8/28/2015)... 2015 Research and ... the "Investigation Report on China,s Insulin Aspart ... Developed by Novo Nordisk, insulin aspart (under ... drug for the treatment of diabetes. Compared with ... insulin analog, starts working fast and reports higher ...
Breaking Medicine Technology:Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... study shows that loss of Arf gene in ... the growth-enhancing environment of the bone,marrow, helping cells ... MEMPHIS, Tenn., Aug. 29 Results of a ... provide strong,evidence for why the drug imatinib (Gleevec(TM)), ...
... Aug. 29 Accera, Inc. announced today,that recent data ... Ketasyn(TM),(AC- 1202) in age-associated memory impairment (AAMI) showed that ... in older adults. AAMI is the decline in ... National Institute of Mental Health criteria for AAMI include,complaints ...
Cached Medicine Technology:St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia 2Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study 2Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study 3
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of furthering ... the second year to the Adams County Fairgrounds in Mendon, IL on May 30th, ... money to support music education in the underfunded school districts of Mendon and its ...
(Date:8/28/2015)... ... , ... As reported by Medical Daily on August 22 , Cellfina, ... last for two years, the longest of any cellulite reduction system currently on the ... long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, director of the ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... who might personally be struggling with chemical dependency, may be able to find ... Rehabilitation, a results-driven holistic treatment center for addiction located in Western Michigan. Focusing ...
(Date:8/28/2015)... ... 28, 2015 , ... Altima Technologies, Inc., the maker of ... center assets and audio-video devices, recently released Visio Stencils for the following product ... Gen9, EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data Systems Virtual ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... the Veterans Award, honoring military veterans leading in business. Mr. Troy Mizell, ... , The inaugural Nashville Business Journal's 2015 Veterans Awards will recognize Nashville ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Altima Updates NetZoomâ„¢ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoomâ„¢ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:MyGenetx Board Member Receives Veterans Award 2
... EXTON, Pa., Nov. 2 Kensey Nash Corporation,(Nasdaq: ... exclusively licensed U.S. patent,6,175,669, Optical Coherence Domain Reflectometry ... expand the intellectual,property portfolio related to its chronic ... with enhanced optical sensing capabilities,allowing it to sense ...
... 24%, Digital Revenue Up 30% ... a.m. Eastern Time, NASHUA, N.H., Nov. 2 iCAD, ... the early detection of cancer, today announced financial,results for the ... nine,months year to date for 2007. Third Quarter 2007 ...
... to get screened for each point scored, CENTENNIAL, ... to great lengths to show support for their favorite ... freezing temperatures, traveling,great distances for the big game. Now ... health by raising awareness of a deadly disease --,prostate ...
... while complying ... US applicable standards, FREDERICA, Del., Nov. 1 ... the pharmaceutical industry,as well as spacesuits for NASA, announced ... use in their DoverPac (R) Containment Solution,products. ArmorFlex (R) ...
... 1 HHS Secretary Mike,Leavitt signed a Memorandum ... Clement today to improve the health status of ... best practices, and innovative approaches to learning,opportunities., ... HHS, national,headquarters., The MOU, which continues the ...
... Inc. (Nasdaq:,IFLG), a leading technology provider of mobile ... release its financial results,for the Third Quarter ended ... the press release, President and Chief Executive Officer,David ... host a conference,call with the financial community at ...
Cached Medicine News:Health News:Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform 2Health News:Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform 3Health News:iCAD Reports Third Quarter Results 2Health News:iCAD Reports Third Quarter Results 3Health News:iCAD Reports Third Quarter Results 4Health News:iCAD Reports Third Quarter Results 5Health News:iCAD Reports Third Quarter Results 6Health News:iCAD Reports Third Quarter Results 7Health News:iCAD Reports Third Quarter Results 8Health News:Professional Football Takes the Field to Tackle Prostate Cancer 2Health News:Professional Football Takes the Field to Tackle Prostate Cancer 3Health News:ILC Dover Launches Revolutionary ArmorFlex (R) Pharmaceutical Product Contact Film 2Health News:HHS Secretary Leavitt Signs Agreement With Canada to Improve Indigenous Health Care Delivery and Access 2Health News:InfoLogix to Report Third Quarter and Nine Month Financial Results on November 8, 2007 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Medicine Products: